In January 2019, Russia imported 797.1 mln RUB worth of pharmaceutical drugs made in the EEU countries (wholesale priced, VAT included), which is in monetary terms 240% higher than that of January 2018. In physical terms, Russia imported 18.2 mln units, which is 260% higher than that of January 2018.

Between January and November 2018, Russia exported 23.5 bln RUB worth of pharmaceutical drugs (customs duties included, exports to the EEU countries excluded), which is in monetary terms 24.5% higher than that of the same period of 2017. In physical terms, the dynamics are -10.3% (473.6 mln units.)

In 2018, Russia imported 64.3 bln RUB worth of veterinary products (free circulation prices), which is in monetary terms 7.8% higher than that in 2017. Feed supplements have the highest import volume in monetary terms (36.5 bln RUB), and the lowest dynamics in monetary terms as well (7.2%.) The import volume of veterinary drugs is 25.9 bln RUB (+8.6% in monetary terms), while that of veterinary APIs is 1.9 bln RUB (+8.1% in monetary terms.)

In 2018, Russia imported 96.5 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 30.6% higher than that in 2017. However, the dynamics are that high mostly due to higher import prices. In physical terms, the dynamics are -3% (11,900 tons.)

In 2018, Russia imported 531 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms only 1.1% higher than that in 2017, and 105.4 bln RUB worth o in-bulk pharmaceuticals, which is in monetary terms 10.3% higher than that in 2017. Despite the high dynamics of the in-bulk import, the import volume is much lower than that in 2016, when it was 111 bln RUB.

Between January and December 2018, Russia imported 9.4 bln RUB worth of pharmaceutical drugs made in the EEU countries (wholesale prices, VAT included), which is in monetary terms 13.1% higher than that of the same period in 2017. The dynamics in physical terms are only +0.9%. The total import volume from Belarus, Kazakhstan, and Armenia amounts to 213.6 mln units.

Unfortunately, 2018 was not a profitable year for Russian pharmaceutical production. In 2018, Russia produced 336 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms only 0.7% higher than that of 2017. These dynamics is the lowest since 2015. In physical terms, the dynamics are -5.3% (4.3 bln units of pharmaceuticals.)

Between January and November 2018, Russia imported 58.5 bln RUB worth of veterinary products (free circulation prices), which is in monetary terms 11.4% higher than that of the same period of 2017. The dynamics of the import of feed supplements in monetary terms are the highest, +11% (33.5 bln RUB), followed by veterinary drugs (+12.2%, 23.3 bln RUB) and veterinary APIs (+8.9%, 1.7 bln RUB.)

Between January and November 2018, Russia imported 475.3 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices, VAT included), which is in monetary terms 0.5% higher than that of the same period of 2017, and 97.3 bln RUB worth of in-bulk drugs, which is 13.6% higher than that of the same period of 2017. The total dynamics in monetary terms are +2.5%.

Between January and November 2018, Russia imported 86.7 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 29.3% lower than that of the same period of 2017. In physical terms, Russia imported 10,600 tons of APIs, which is 5% lower than that of the same period of 2017.